Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Serum beta 2-microglobulin and ankylosing spondylitis].

D Wendling1, J Mas, F Chatelain

  • 1Service de Rhumatologie, Hôpital J.-Minjoz, Besançon.

Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires
|May 1, 1989
PubMed
Summary

Serum beta-2-microglobulin (B2-m) levels are normal in ankylosing spondylarthritis patients. Notably, B2-m levels were lower in HLA-B27 positive individuals, suggesting a potential link.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of serum insulin-like growth factor 1 concentrations in non-diabetic cats with chronic kidney disease.

Domestic animal endocrinology·2024
Same author

Increased insulin-like growth factor 1 concentrations in a population of non-diabetic cats with overweight/obesity.

Domestic animal endocrinology·2024
Same author

A treadmill exercise reduced cardiac fibrosis, inflammation and vulnerability to ischemia-reperfusion in rat pristane-induced arthritis.

Life sciences·2024
Same author

Electrochemical biosensor for aerobic acetate detection.

Talanta·2023
Same author

Is off-label thrombolysis safe and effective in a real-life primary stroke center? A retrospective analysis of data from a 5-year prospective database.

Revue neurologique·2022
Same author

Endovascular treatment for acute ischemic stroke at a primary stroke center: First results of the Perpignan center.

Revue neurologique·2021

Area of Science:

  • Immunology
  • Rheumatology
  • Biochemistry

Context:

  • Ankylosing spondylarthritis (AS) is a chronic inflammatory disease primarily affecting the spine.
  • Biomarkers are crucial for understanding disease mechanisms and progression in AS.
  • Serum beta-2-microglobulin (B2-m) is a protein found on the surface of most nucleated cells, its levels can be altered in various conditions.

Purpose:

  • To evaluate serum beta-2-microglobulin (B2-m) levels in patients with ankylosing spondylarthritis (AS).
  • To investigate the correlation of B2-m levels with clinical and immunological parameters in AS.
  • To explore the relationship between B2-m levels and HLA-B27 status in AS patients.

Summary:

  • Serum B2-m levels were measured in 28 AS patients using radioimmunoassay.
  • Mean B2-m levels were within normal limits and did not correlate with disease activity, treatment status, or other immunological markers (Sed Rate, IgA, CD3+, CD4+, CD8+, Leu 7, NK activity).
  • A significant finding was that mean B2-m levels were lower in HLA-B27 positive patients compared to HLA-B27 negative patients. The study also discussed the potential interference of anti-B2-m antibodies in the assay.

Impact:

  • This study suggests that serum B2-m may not be a reliable biomarker for disease activity in AS.
  • The observed inverse correlation between B2-m levels and HLA-B27 positivity warrants further investigation into the immunopathogenesis of AS.
  • Findings may prompt research into the role of anti-B2-m antibodies and their influence on B2-m assays in autoimmune diseases.

Related Experiment Videos